Cell Cycle/DNA Damage

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC11863	CA224	A non-planar analogue of fascaplysin that selectively inhibits CDK4/cyclin D1 with IC50 of 5.5 uM. More description
DC11851	Clitocine	A naturally occurring nucleoside analog that possesses antitumor activity, also is a potent and efficacious readthrough agent. More description
DC11718	Debromohymenialdisine	A marine sponge alkaloid that inhibits Chk1 and Chk2 with IC50 of 3 and 3.5 uM, respectively. More description
DC11779	TNKS-IN-41	A highly potent and selective tankyrase inhibitor with pIC50 of 8.5 and 8.1 for TNKS1 and TNKS2, respectively. More description
DC11932	GPX-150	A doxorubicin analog that demonstrates anti-cancer activity without cardiotoxicity, does not inhibit topoisomerase IIβ activity at 100 uM. More description
DC11874	CDK12 inhibitor E9 racemate	A clinical analog of THZ1 and a selective, covalent CDK12 inhibitor that is not susceptible to ABC transporter-mediated drug efflux. More description
DC11873	CDK12 inhibitor E9 R-isomer	A clinical analog of THZ1 and a selective, covalent CDK12 inhibitor that is not susceptible to ABC transporter-mediated drug efflux. More description
DC8944	5-Fluorouracil	5-Fluorouracil is a potent antitumor agent that affects pyrimidine synthesis by inhibiting thymidylate synthetase thus depleting intracellular dTTP pools. More description
DCK-004	corilagin	>98%,Standard References More description
DCZ-158	CALCIUML-5-METHYLTETRAHYDROFOLATE	>98%,Standard References More description